ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,702.55
-0.19%
US Tech 100
19,318.40
0.11%
Dow Jones
42,063.36
0.09%
Brent Oil
74.055
0.23%
Bitcoin
63,576.66
-0.07%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Cellectis Nom Eo 05 (ALCLS) Quote

Cellectis Nom Eo 05

Cellectis Nom Eo 05 (ALCLS)

EU
1.976
0.008
( 0.41% )
Updated: 05:52:56
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.976
Bid
1.974
Ask
1.978
Volume
43,023
1.97 Day's Range 2.045
0.888 52 Week Range 3.44
Market Cap
90.649M
Previous Close
1.968
Open
2.045
Last Trade
88
@
1.976
Last Trade Time
05:52:56
Financial Volume
-
VWAP
-
Average Volume (3m)
45,327
Shares Outstanding
45,874,895
Dividend Yield
-
PE Ratio
-1.15
Earnings Per Share (EPS)
-2.2
Revenue
9.24M
Net Profit
-101.06M

About Cellectis Nom Eo 05

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cellectis.com
Headquarters
Paris, Paris, Fra
Founded
-
Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 1.97 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 0.888 € to 3.44 €.

Cellectis Nom Eo 05 currently has 45,874,895 shares outstanding. The market capitalization of Cellectis Nom Eo 05 is 90.28 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -1.15.

Ask ADVFN Intelligence (AI)

ALCLS Latest News

More News

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 04...

September 04 2024
UK Regulatory

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Listing...

September 04 2024
UK Regulatory

Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety

Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”...

September 03 2024
UK Regulatory

Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

September 03 2024
GlobeNewswire Inc.

Cellectis présente des preuves précliniques de l’efficacité des cellules CAR T MUC1 contre le cancer du sein triple négatif tout en préservant la sécurité

Cellectis présente des preuves précliniques de l’efficacité des cellules CAR T MUC1 contre le cancer du sein triple négatif tout en préservant la sécurité NEW YORK, 03 sept. 2024 (GLOBE...

September 03 2024
UK Regulatory

Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors

Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”...

August 26 2024
UK Regulatory

Cellectis publie un article dans Molecular Therapy sur la conception de cellules CAR T pour le traitement de tumeurs solides récalcitrantes

Cellectis publie un article dans Molecular Therapy sur la conception de cellules CAR T pour le traitement de tumeurs solides récalcitrantes NEW YORK, 26 août 2024 (GLOBE NEWSWIRE...

August 26 2024
UK Regulatory

Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

August 26 2024
GlobeNewswire Inc.

Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer

Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage...

August 07 2024
UK Regulatory

Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

August 07 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.114-5.454545454552.092.091.964285842.02679344DE
4-0.119-5.680190930792.0952.171.964301972.0503814DE
120.32819.90291262141.6482.171.642453271.9109781DE
26-0.384-16.27118644072.363.0251.634759732.26010433DE
520.456301.523.440.8881737942.49178754DE
156-9.744-83.139931740611.7211.750.8881663293.2127696DE
260-8.764-81.601489757910.7428.450.8881419436.69077102DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DMSBSDiagnostic Medical Systems
0.006 €
(200.00%)
73
ALCOXNicox SA
0.299 €
(47.29%)
2.49M
SQISqli
54.00 €
(37.06%)
127.74k
ALACTActicor Biotech
0.38 €
(22.58%)
39.05k
LVIDELavide Holdings NV
0.378 €
(18.13%)
103.2k
MLSUMSumo Resourcs Plc
0.0055 €
(-45.00%)
50k
MLSMLSmalto
0.0105 €
(-41.67%)
377
MLEFAEduformAction
0.486 €
(-14.74%)
10.04k
ALVIAVialife Sa
12.00 €
(-14.29%)
50
TVRBAction Televerbier
55.00 €
(-11.29%)
1
BCPBanco Comercial Portugues SA
0.4129 €
(-1.43%)
25.71M
ALAVEAventador
0.0038 €
(-5.00%)
16.58M
LOCALSolocal Groupe
0.0029 €
(0.00%)
9.51M
ALTDTonner Drones
0.0086 €
(4.88%)
7.51M
ALDOLDolfines
0.0006 €
(0.00%)
3.98M

Discussion

View Full Feed
ANTI-BAGHOLDER ANTI-BAGHOLDER 2 minutes ago
Grow up dude. I got a bunch of .0008’s. Which was My original target from about 2 months ago.

All I was doing was showing people that the notes are going to destroy a good share structure. Float was 15 million 2 mo the ago.

Now over 400 million.

A
SINC
crazyflavor crazyflavor 2 minutes ago
So why didn’t they stay private? I don’t buy the they wanted to give the avg person a chance. Also paying stock promoters looks really bad too.
VRSSF
north40000 north40000 3 minutes ago
This morning, APO offers to invest $5Billion in INTC, per CNBC-TV.
INTC
reena969 reena969 3 minutes ago
NVVE 30% exit $6.70 ...Seems I left too early Didn't expect the R/S pump to last, being it's the second one.
NVVE
urge2surge urge2surge 3 minutes ago
Part II
Kansas City Chiefs VS Atlanta Falcons 8:20 pm EST

WW AI picks the Kansas City Chiefs playing the money line

Jacksonville Jaguars VS Buffalo Bills 4:30 pm EST

WW AI Cited a last injury report and picks the Buffalo Bills playing the money lin
IDVV
ksquared ksquared 4 minutes ago
I'd love to hear this guy's life story...
6-year-old boy abducted from California in 1951 found safe on East Coast after 70-year search
By Caitlin McCormack Published Sep. 22, 2024, 9:38 p.m. ET

A California family’s 70-year-long search for thei
tradernewstip tradernewstip 4 minutes ago
$AGBA ~ AGBA + Triller MEGA MERGER.....
AGBA Group Announces Results of Extraordinary General Meeting of Shareholders

AGBA’s merger with Triller Corp. is on track to close
Shareholder approval was granted for AGBA to be incorporated as a Delaware Corporation and domicile
AGBA
DAR53 DAR53 4 minutes ago
north40000, thanks for your posts, and specifically this one related to CVS. And, I am especially impressed with your willingness to stand up for V and to pay the ~$1000 for approved V instead of accepting an AG. Then, per RMB's follow-up response that CVS offers various AG's and not V for the CVD
CVS
DKLN DKLN 5 minutes ago
For people who assert that something will be happening "soon" (the pushers have looked stupi - I mean clueless - for years using "soon " as nothing positive as ever happened), try specifying a timeframe instead of using the vague, meaningless "soon". Let's see if anyone has the courage to define a t
MCIC
urge2surge urge2surge 5 minutes ago
NFL Week 3 Picks
The top sports picks and information you need to know

The AI has generated its picks for this afternoon. Thank you again for subscribing to our beta version, let's get to it with the top picks generated by our Winners Waygers AI!

Please note ther
IDVV
capgain capgain 5 minutes ago
You too, have a good one.
Samuel J Samuel J 6 minutes ago
From a CLOWN that calls 2.2 and drops to 1.4.

😂
TGRP
mrwilson31 mrwilson31 7 minutes ago
You knew when you retired?
XCRT
TrendTrade2016 TrendTrade2016 7 minutes ago
WATCH AND LEARN
TGRP
mrsdoubtfire mrsdoubtfire 7 minutes ago
out of court settlementd happen she found out vakster had a sissy lover and wanted to keep It secret

now Eddie mové out of their home and still lives in Texas with matthew
AURI
nowwhat2 nowwhat2 7 minutes ago
https://investorshub.advfn.com/uimage/uploads/2024/9/23/puugobtc_999_23_capt_1y_3am_64_BO_PLAIN.jpg
BTCUSD
capgain capgain 7 minutes ago
The Chargers and Raiders are both pretenders!
ksquared ksquared 8 minutes ago
Excellent find, cap. Someone has to be feeding policy to Jill.
Here's to the new week.
Hope it treats you well.
justhefax justhefax 9 minutes ago
There has been significant dilution this year.

And years past the co proposed a crypto sideline. But not aligned in any way to core biz so discontinued.

Best to stick with their knitting.

KGKG
Horsts Horsts 9 minutes ago
I'm curious to see if anyone gets anything, and if so, how much. Experience shows that nobody will get anything, except maybe the CEO and his best buddies. I wouldn't be surprised if nothing happens. And the EPAZ share price simply falls again by 80%. I wouldn't be too optimistic here.
EPAZ
CarlCarlMcB CarlCarlMcB 9 minutes ago
In compliance $$$$$$$$$$
AGRI
Samuel J Samuel J 10 minutes ago
Laughable from a CLOWN that calls at 2.2 and then it drops to 1.4.

😂
TGRP
toohot toohot 11 minutes ago
BIEL up over 33% after Friday’s close. It’s not surprising Barchart rates BIEL as a BUY!!!


Overall Average:
56% BUY
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, wh
BIEL

Your Recent History

EU
ALCLS
Cellectis Nom Eo 05
NYSE
MOH
Molina Healthcare
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved